logo
Select company
Select metric
$ 10.47MNet Cash Flow - Financing
VS
Market
33
Sector
43
Industry
52
History
-
$ 3.03Close
$ 1.6 - $ 3.99 52-Week Range
Ticker Information

Ticker

NRXS

Company Name

NEURAXIS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NEURAXIS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRXS - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 10.47M
3/31/2025$ 8.32M
12/31/2024$ 9.74M
9/30/2024$ 6.51M
6/30/2024$ 10.19M
3/31/2024$ 7.52M
12/31/2023$ 6.59M
9/30/2023$ 5.14M
12/31/2022$ 2.29M
12/31/2021$ 661.1K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEURAXIS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 661.1K.
  • Over the past 5 years, NEURAXIS INC's average CF - Financing has been $ 6.74M.
  • The median CF - Financing for NEURAXIS INC during this period was $ 7.05M
  • NEURAXIS INC reached its highest CF - Financing over the past 5 years at $ 10.47M.
  • The lowest CF - Financing recorded by NEURAXIS INC in the same timeframe $ 661.1K

NEURAXIS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
CAMP : CAMP4 THERAPEUTICS CORP $ 72.78MDYAI : DYADIC INTERNATIONAL INC $ 48.5KLPCN : LIPOCINE INC $ 75.62KTRAW : TRAWS PHARMA INC $ 23.09MLSTA : LISATA THERAPEUTICS INC $ -55KSTTK : SHATTUCK LABS INC $ -106KSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ 7.09MLGVN : LONGEVERON INC $ 13.48MBOLT : BOLT BIOTHERAPEUTICS INC $ 43KCLSD : CLEARSIDE BIOMEDICAL INC $ 2.02M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

NRXS - Net Cash Flow - Financing, Last 5 years

$ 661.1K

Minimum

Dec 31, 2021

$ 10.47M

Maximum

Jun 30, 2025

$ 6.74M

Average

$ 7.05M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.25M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.25M